Billionaire entrepreneur and top adviser to President-elect Donald Trump, Elon Musk, touted that he has reaped the benefits of a controversial class of weight-loss drugs, after fellow top Trump ...
The drugs that Novo Nordisk and Eli Lilly market for the treatment of obesity and diabetes are flying off pharmacy shelves and have further to climb. A report from Morgan Stanley suggests the market ...